Treatment of Epiretinal Membranes With Ranibizumab

Summary

The purpose of this study is to determine whether intraocular injection of ranibizumab decreases the retinal thickness in patients with epiretinal membranes and reduces associated symptoms.

Timeline

Start

2010-11

Primary completion

2011-11

Completion

2012-01

Drugs

Indications